Park Place Capital Corp Increases Stake in Altria Group

Business by 2FIRSTS.ai
Nov.03.2023
Park Place Capital Corp Increases Stake in Altria Group
Park Place Capital Corp increased its stake in Altria Group by 278.5% in the second quarter, according to Riverton Roll.

According to a report by the American media outlet Riverton Roll on November 1st, Park Place Capital Corp has revealed in its recent 13F filing with the US Securities and Exchange Commission that the company increased its stake in Altria Group by 278.5% during the second quarter.

 

During this period, Park Place increased its holdings in the company by 1,958 shares, bringing its total holdings to 2,661 shares. Currently, the company holds stocks of Occhia Group valued at $12.1 million.

 

Park Prices is an American investment advisory company, according to its latest filing with the U.S. Securities and Exchange Commission, Park Prices' stake in Altria Group is valued at $121,000.

 

Several other institutional investors and hedge funds have recently adjusted their holdings in Altria Group. Loomis Sayles & Co. LP purchased new shares of Altria Group in the first quarter, amounting to approximately $25,000. Northwest Bank & Trust Co acquired new shares of Altria Group in the second quarter, valued at around $27,000.

 

Ellevest Inc., a limited company, increased its stake in Altria Group by 346.7% in the first quarter. Ellevest now holds 670 shares of the company, worth $30,000, after purchasing an additional 520 shares in the previous quarter. NewSquare Capital LLC, in the first quarter, increased its holdings of Altria Group stock by 153.8%. During this period, NewSquare purchased an additional 443 shares and currently holds 731 shares of the company, worth $33,000. Lastly, Jefferies Financial Group Inc. acquired a new position in Altria stock during the fourth quarter, valued at approximately $34,000.

 

Institutional investors and hedge funds collectively hold 58.94% of the company's shares.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai
Maldives Customs Report Vape Fines Reach  US$42.8 Million, Mostly from Malaysia Imports
Maldives Customs Report Vape Fines Reach US$42.8 Million, Mostly from Malaysia Imports
Maldives Customs data shows that fines related to illegal vapes have reached MVR 659 million (about US$42.8 million) since the country banned the import and use of electronic cigarettes. Authorities said most seized vapes were brought in by travellers arriving from Malaysia. The largest single case involved 10,800 vapes, resulting in a fine of MVR 108 million (about US$7.02 million).
Dec.23 by 2FIRSTS.ai
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.
Dec.10 by 2FIRSTS.ai
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia proposes tax rate adjustments on e-cigarette devices and e-liquids, with penalties for late reporting. Effective from July 1, 2026.
Feb.02 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai